Follow
Rita Ambrus
Rita Ambrus
Verified email at pharm.u-szeged.hu
Title
Cited by
Cited by
Year
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam
R Ambrus, P Kocbek, J Kristl, R Šibanc, R Rajkó, P Szabó-Révész
International journal of pharmaceutics 381 (2), 153-159, 2009
1132009
Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation
E Pallagi, R Ambrus, P Szabó-Révész, I Csóka
International journal of pharmaceutics 491 (1-2), 384-392, 2015
862015
Betulinic Acid in Complex with a Gamma-Cyclodextrin Derivative Decreases Proliferation and in Vivo Tumor Development of Non-Metastatic and Metastatic …
C Soica, C Danciu, G Savoiu-Balint, F Borcan, R Ambrus, I Zupko, F Bojin, ...
International journal of molecular sciences 15 (5), 8235-8255, 2014
842014
Betulin Complex in γ-Cyclodextrin Derivatives: Properties and Antineoplasic Activities in In Vitro and In Vivo Tumor Models
C Şoica, C Dehelean, C Danciu, HM Wang, G Wenz, R Ambrus, F Bojin, ...
International Journal of Molecular Sciences 13 (11), 14992-15011, 2012
642012
Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology
A Szűts, P Láng, R Ambrus, L Kiss, MA Deli, P Szabó-Révész
International journal of pharmaceutics 410 (1-2), 107-110, 2011
532011
Improvement of ursolic and oleanolic acids’ antitumor activity by complexation with hydrophilic cyclodextrins
C Oprean, M Mioc, E Csányi, R Ambrus, F Bojin, C Tatu, M Cristea, A Ivan, ...
Biomedicine & Pharmacotherapy 83, 1095-1104, 2016
522016
Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery
T Athamneh, A Amin, E Benke, R Ambrus, CS Leopold, P Gurikov, ...
The journal of supercritical fluids 150, 49-55, 2019
512019
Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles
L Kürti, Á Kukovecz, G Kozma, R Ambrus, MA Deli, P Szabó-Révész
Powder technology 212 (1), 210-217, 2011
502011
Water-soluble loratadine inclusion complex: analytical control of the preparation by microwave irradiation
A Nacsa, R Ambrus, O Berkesi, P Szabo-Revesz, Z Aigner
Journal of pharmaceutical and biomedical analysis 48 (3), 1020-1023, 2008
492008
Genistein in 1: 1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation
C Danciu, C Soica, M Oltean, S Avram, F Borcan, E Csanyi, R Ambrus, ...
International journal of molecular sciences 15 (2), 1962-1982, 2014
472014
Electrospray crystallization for nanosized pharmaceuticals with improved properties
N Radacsi, R Ambrus, T Szunyogh, P Szabó-Révész, A Stankiewicz, ...
Crystal growth & design 12 (7), 3514-3520, 2012
472012
Intranasal nanoparticulate systems as alternative route of drug delivery
A Alshweiat, R Ambrus, II Csóka
Current medicinal chemistry 26 (35), 6459-6492, 2019
452019
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
K Karimi, E Pallagi, P Szabó-Révész, I Csóka, R Ambrus
Drug design, development and therapy 10, 3331, 2016
452016
New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach
E Pallagi, K Karimi, R Ambrus, P Szabó-Révész, I Csóka
International journal of pharmaceutics 511 (1), 151-160, 2016
432016
In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration
L Kürti, R Gáspár, Á Márki, E Kápolna, A Bocsik, S Veszelka, C Bartos, ...
European Journal of Pharmaceutical Sciences 50 (1), 86-92, 2013
422013
Analysis of co-spray-dried meloxicam–mannitol systems containing crystalline microcomposites
A Pomázi, R Ambrus, P Sipos, P Szabó-Révész
Journal of pharmaceutical and biomedical analysis 56 (2), 183-190, 2011
422011
The effect of the antioxidant on the properties of thiolated poly (aspartic acid) polymers in aqueous ocular formulations
M Budai-Szűcs, G Horvát, B Gyarmati, BÁ Szilágyi, A Szilágyi, S Berkó, ...
European Journal of Pharmaceutics and Biopharmaceutics 113, 178-187, 2017
412017
Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid
K Takács-Novák, V Szőke, G Völgyi, P Horváth, R Ambrus, ...
Journal of pharmaceutical and biomedical analysis 83, 279-285, 2013
402013
Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam
A Pomázi, F Buttini, R Ambrus, P Colombo, P Szabó-Révész
European Polymer Journal 49 (9), 2518-2527, 2013
382013
Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery
A Chvatal, R Ambrus, P Party, G Katona, O Jójárt-Laczkovich, ...
International Journal of Pharmaceutics 559, 68-75, 2019
352019
The system can't perform the operation now. Try again later.
Articles 1–20